Kazia Therapeutics (KZIA) Other Non-Current Assets (2018 - 2025)
Kazia Therapeutics' (KZIA) quarterly Other Non-Current Assets came in at $138207.8 in Q4 2025, down 14.18% YoY from $161035.5 in Q4 2024, and down 56.01% on a QoQ basis from $314169.6 in Q2 2025.
Kazia Therapeutics (KZIA) Other Non-Current Assets (2018 - 2025) Analysis & Trends
Kazia Therapeutics (KZIA) has 7 years of Other Non-Current Assets data on file, last reported at $138207.8 in Q4 2025.
- Quarterly Other Non-Current Assets fell 14.18% year-over-year to $138207.8 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $138207.8 (down 14.18% YoY) and the FY2025 annual result came in at $314169.6, down 19.36% from the prior year.
- Other Non-Current Assets retreated to $138207.8 in Q4 2025, from $314169.6 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.3 million in Q2 2021 to a low of $138207.8 in Q4 2025.
- A 4-year average of $616051.9 and a median of $423731.2 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets surged 276.04% — and 2024, when it tumbled 64.83%.
- Tracing KZIA's Other Non-Current Assets over 4 years: stood at $1.1 million in 2021, then tumbled by 56.48% to $457872.2 in 2023, then sank by 64.83% to $161035.5 in 2024, then slipped by 14.18% to $138207.8 in 2025.
- The last three Other Non-Current Assets figures came in at $138207.8 (Q4 2025), $314169.6 (Q2 2025), and $161035.5 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 138,207.84 |
| Jun 30, 2025 | 314,169.63 |
| Dec 31, 2024 | 161,035.50 |
| Jun 30, 2024 | 389,590.23 |
| Dec 31, 2023 | 457,872.20 |
| Jun 30, 2023 | 1.09 Mn |
| Dec 31, 2021 | 1.05 Mn |
| Jun 30, 2021 | 1.32 Mn |
| Dec 31, 2020 | 738,787.94 |
| Jun 30, 2020 | 352,160.78 |
| Dec 31, 2019 | 123,787.68 |
| Jun 30, 2019 | 258,897.35 |
| Dec 31, 2018 | 103,361.77 |
| Jun 30, 2018 | 581,369.53 |